Sam completed a Masters of Brain and Mind Sciences from the University of Sydney, following a Bachelor of Science (Biochemistry/Computer Science) from the ANU. As a PhD student in the Medicinal Chemistry & Drug Discovery research group, his current project involves the development of 3D, human iPSC-derived models for the modelling of brain disorders. The focus of this project involves the investigation of vascular pathology in Alzheimer's Disease.
Previously, Sam held a Research Assistant position in the Medicinal Chemistry & Drug Discovery research group where he performed pre-clinical animal research investigating the transcriptomic and proteomic changes induced by a novel anti-addictive agent. He also explored the potential of novel cannabinoids in the imaging and treatment of neuroinflammation. Before this, Sam's Master's project focused on the binding and functional activity of novel CB2 ligands on microglial polarisation for potential development as imaging/therapeutic agents for neuroinflammation.